| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
92,933 |
72,445 |
$2.45M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
49,829 |
42,234 |
$1.06M |
| 96367 |
|
26,204 |
16,486 |
$990K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
25,788 |
16,569 |
$810K |
| Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram |
6,897 |
1,825 |
$807K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
262 |
175 |
$781K |
| J9271 |
Injection, pembrolizumab, 1 mg |
235 |
179 |
$701K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
24,529 |
14,695 |
$503K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
30,975 |
15,812 |
$461K |
| 99233 |
Prolong inpt eval add15 m |
19,542 |
5,348 |
$444K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
7,668 |
5,153 |
$426K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15,046 |
10,203 |
$406K |
| J0897 |
Injection, denosumab, 1 mg |
770 |
744 |
$373K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
1,229 |
1,178 |
$353K |
| J9306 |
Injection, pertuzumab, 1 mg |
120 |
87 |
$338K |
| 99205 |
Prolong outpt/office vis |
6,146 |
6,135 |
$284K |
| 36415 |
Collection of venous blood by venipuncture |
11,465 |
8,920 |
$246K |
| Q5114 |
Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg |
147 |
89 |
$239K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,095 |
4,295 |
$206K |
| Q5117 |
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg |
133 |
103 |
$186K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
21,810 |
13,623 |
$174K |
| Q5129 |
Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg |
166 |
85 |
$149K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
220 |
211 |
$128K |
| 96417 |
|
5,330 |
3,848 |
$123K |
| J1453 |
Injection, fosaprepitant, 1 mg |
684 |
440 |
$121K |
| J9171 |
Injection, docetaxel, 1 mg |
1,066 |
718 |
$119K |
| 99223 |
Prolong inpt eval add15 m |
2,840 |
2,736 |
$113K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,827 |
11,310 |
$93K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,923 |
1,338 |
$85K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
17,514 |
9,251 |
$84K |
| J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg |
383 |
365 |
$79K |
| J9070 |
Cyclophosphamide, 100 mg |
160 |
102 |
$65K |
| 80053 |
Comprehensive metabolic panel |
2,972 |
2,237 |
$65K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,069 |
2,924 |
$63K |
| 96127 |
|
17,783 |
17,633 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,039 |
1,039 |
$56K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,136 |
1,412 |
$46K |
| 96402 |
|
2,832 |
2,695 |
$32K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,981 |
2,036 |
$31K |
| 96415 |
|
2,625 |
1,852 |
$30K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
65 |
63 |
$29K |
| 99215 |
Prolong outpt/office vis |
1,812 |
1,650 |
$29K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,366 |
2,361 |
$24K |
| J1756 |
Injection, iron sucrose, 1 mg |
686 |
323 |
$20K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
348 |
348 |
$18K |
| J3489 |
Injection, zoledronic acid, 1 mg |
551 |
516 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,350 |
1,959 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
977 |
701 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
379 |
347 |
$8K |
| J1566 |
Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg |
16 |
15 |
$6K |
| J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram |
37 |
12 |
$6K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,669 |
2,354 |
$3K |
| J9045 |
Injection, carboplatin, 50 mg |
186 |
129 |
$3K |
| 96411 |
|
210 |
150 |
$2K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
14 |
12 |
$1K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
27 |
25 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
13 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
731 |
663 |
$337.59 |
| J9395 |
Injection, fulvestrant, 25 mg |
26 |
12 |
$320.96 |
| 80076 |
|
702 |
642 |
$287.87 |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
13 |
12 |
$275.94 |
| 82728 |
|
253 |
250 |
$218.93 |
| 96401 |
|
23 |
13 |
$94.74 |
| 82746 |
|
112 |
112 |
$83.84 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
16 |
16 |
$46.00 |
| 82607 |
|
34 |
34 |
$41.50 |
| 96523 |
|
26 |
24 |
$35.09 |
| 85379 |
|
13 |
12 |
$22.75 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
355 |
350 |
$0.00 |